These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9269757)
1. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. Uchida T; Kinoshita T; Nagai H; Nakahara Y; Saito H; Hotta T; Murate T Blood; 1997 Aug; 90(4):1403-9. PubMed ID: 9269757 [TBL] [Abstract][Full Text] [Related]
2. High-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B gene. Uchida T; Kinoshita T; Hotta T; Murate T Leuk Lymphoma; 1998 Dec; 32(1-2):9-18. PubMed ID: 10036997 [TBL] [Abstract][Full Text] [Related]
3. Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes. Aoki E; Uchida T; Ohashi H; Nagai H; Murase T; Ichikawa A; Yamao K; Hotta T; Kinoshita T; Saito H; Murate T Leukemia; 2000 Apr; 14(4):586-93. PubMed ID: 10764143 [TBL] [Abstract][Full Text] [Related]
4. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795 [TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Xing EP; Nie Y; Wang LD; Yang GY; Yang CS Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Herman JG; Jen J; Merlo A; Baylin SB Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes. Chen H; Wu S Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726 [TBL] [Abstract][Full Text] [Related]
10. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Drexler HG Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410 [TBL] [Abstract][Full Text] [Related]
11. p16INK4A and p15INK4B gene deletions in primary leukemias. Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas. Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas. Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195 [TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182 [TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333 [TBL] [Abstract][Full Text] [Related]
17. Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes. Aoki E; Ohashi H; Uchida T; Murate T; Saito H; Kinoshita T Leukemia; 2003 Sep; 17(9):1903-4. PubMed ID: 12970793 [No Abstract] [Full Text] [Related]
18. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408 [TBL] [Abstract][Full Text] [Related]
19. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
20. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs]. Ye XS; Liu T; Cui X; Meng WT; Xi YM Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]